Anzeige
Mehr »
Login
Sonntag, 17.01.2021 Börsentäglich über 12.000 News von 656 internationalen Medien
Ganz selten: Bewegende Meldung! Wird mit dieser News am Montag ein Super-Hype ausgelöst?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FierceBiotech

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrNextCure nabs NexImmune, Celgene research vet as new CMO 6 months after former CMO quit
FrCambridge Univ. researchers develop DNA test for COVID-19's secondary, hospital-acquired infections
FrJPM: Thermo Fisher picks up Novasep's viral vector business for $878M outright
FrLandos Biopharma guns for a $100 million IPO to boost AI autoimmune R&D work
FrEli Lilly chips $30M into VC fund aimed at minority-owned healthcare companies
FrHow a gene linked to the circadian clock could point to new prostate cancer treatments
FrSinopharm claims COVID-19 vaccine safe in kids aged 3 and up
FrParexel, Signify join forces to better diversity in clinical trials
FrEx-Merck scientist accused of stealing trade secrets on Keytruda, raising threat of 10-year prison term
FrChutes & Ladders-Bristol Myers hematology chief Ahmed hits exit
FrAI cancer pathology developer Paige nets $100M in venture capital funding
DoPhilips joins Merck KGaA to develop AI-guided fertility treatments
DoJPM: Can we take J.P. Morgan out of San Francisco? We're virtually there
DoEye stem cell transplant to treat blindness bolsters retinal function in monkeys
DoMeet Binney Street Capital: Dana-Farber Cancer Institute's first venture fund
DoKnopp's oral asthma drug hits primary endpoint in phase 2
DoNewAmsterdam bags $196M to resurrect Amgen's discarded CETP drug
DoSecretive Sana, still a year away from the clinic, files for an IPO after a mammoth raise
MiJPM: Alector, Annexon, Athira on what an aducanumab approval could mean for Alzheimer's R&D
MiCognito Therapeutics nets FDA breakthrough label for light, sound therapy for Alzheimer's disease
MiJPM: Imara CEO Ballal on fighting sickle cell disease during COVID-19
MiJPM, Day 3: CureVac partner Bayer says not to discount its vaccine efforts, CROs better prepped for new wave and more
MiJPM: Aridis CEO Truong on why the pandemic hasn't bolstered antibiotics R&D and what needs to change
MiJPM: CureVac's new pharma partner Bayer says its COVID-19 vaccine not just an also-ran
MiA COVID-19 treatment candidate that fuses tiny antibodies from llamas and alpacas shows promise
sist1